# Tomosynthesis as Primary Test for Breast Cancer Screening

> **NCT04461808** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Azienda USL Reggio Emilia - IRCCS** · enrollment: 10156 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** tomosynthesis + synthetic 2D
- **DIAGNOSTIC_TEST:** digital mammography

## Key facts

- **NCT ID:** NCT04461808
- **Lead sponsor:** Azienda USL Reggio Emilia - IRCCS
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-07-15
- **Primary completion:** 2027-04-30
- **Final completion:** 2029-04-30
- **Target enrollment:** 10156 (ACTUAL)
- **Last updated:** 2025-06-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04461808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04461808, "Tomosynthesis as Primary Test for Breast Cancer Screening". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04461808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*